Johan Bohr

4.1k total citations
65 papers, 2.5k citations indexed

About

Johan Bohr is a scholar working on Epidemiology, Genetics and Dermatology. According to data from OpenAlex, Johan Bohr has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 34 papers in Genetics and 23 papers in Dermatology. Recurrent topics in Johan Bohr's work include Microscopic Colitis (61 papers), Inflammatory Bowel Disease (33 papers) and Hidradenitis Suppurativa and Treatments (23 papers). Johan Bohr is often cited by papers focused on Microscopic Colitis (61 papers), Inflammatory Bowel Disease (33 papers) and Hidradenitis Suppurativa and Treatments (23 papers). Johan Bohr collaborates with scholars based in Sweden, United States and United Kingdom. Johan Bohr's co-authors include Curt Tysk, Gunnar Järnerot, S. Eriksson, Sune Eriksson, Nils Nyhlin, Hasse Abrahamsson, Anna Wickbom, Henrik Hjortswang, Elisabeth Hultgren Hörnquist and Magnus Ström and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Johan Bohr

63 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Bohr Sweden 31 2.2k 1.6k 1.2k 470 458 65 2.5k
Eugene F. Yen United States 15 468 0.2× 238 0.2× 148 0.1× 237 0.5× 185 0.4× 40 932
Eric Vasiliauskas United States 13 470 0.2× 616 0.4× 61 0.1× 238 0.5× 158 0.3× 20 894
Andrew Ippoliti United States 22 462 0.2× 540 0.3× 34 0.0× 685 1.5× 350 0.8× 34 1.3k
G d'Albasio Italy 20 997 0.5× 1.2k 0.7× 25 0.0× 472 1.0× 113 0.2× 30 1.5k
David F. Hutcheon United States 14 257 0.1× 446 0.3× 60 0.1× 325 0.7× 178 0.4× 22 1.5k
Valentina Discepolo Italy 19 468 0.2× 190 0.1× 34 0.0× 434 0.9× 690 1.5× 45 1.1k
Edyta Zagórowicz Poland 11 959 0.4× 1.2k 0.8× 11 0.0× 539 1.1× 165 0.4× 29 1.6k
Nobuyuki Hida Japan 20 496 0.2× 691 0.4× 19 0.0× 422 0.9× 100 0.2× 57 1.2k
Alicia Algaba Spain 20 491 0.2× 699 0.4× 17 0.0× 480 1.0× 89 0.2× 68 1.3k
Benedetta Terziroli Beretta‐Piccoli Switzerland 19 786 0.4× 70 0.0× 166 0.1× 310 0.7× 15 0.0× 49 1.5k

Countries citing papers authored by Johan Bohr

Since Specialization
Citations

This map shows the geographic impact of Johan Bohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Bohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Bohr more than expected).

Fields of papers citing papers by Johan Bohr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Bohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Bohr. The network helps show where Johan Bohr may publish in the future.

Co-authorship network of co-authors of Johan Bohr

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Bohr. A scholar is included among the top collaborators of Johan Bohr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Bohr. Johan Bohr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engel, Peter J., Vincenzo Villanacci, Jeppe Thagaard, et al.. (2021). Histological disease activity in patients with microscopic colitis is not related to clinical disease activity or long‐term prognosis. Alimentary Pharmacology & Therapeutics. 54(1). 43–52. 5 indexed citations
2.
Münch, Andreas, Emese Mihály, Ferenc Nagy, et al.. (2021). Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo‐controlled multicentre trial. United European Gastroenterology Journal. 9(7). 837–847. 5 indexed citations
3.
Larsson, J., Konstantinos J. Dabos, Peter Höglund, et al.. (2019). Cancer Risk in Collagenous Colitis. Journal of Clinical Medicine. 8(11). 1942–1942. 9 indexed citations
4.
Svensson, Magnus, David Bergman, Ola Olén, et al.. (2018). Validating microscopic colitis (MC) in Swedish pathology registers. Scandinavian Journal of Gastroenterology. 53(12). 1469–1475. 33 indexed citations
5.
Wickbom, Anna, Johan Bohr, Nils Nyhlin, et al.. (2018). Microscopic colitis in patients with ulcerative colitis or Crohn’s disease: a retrospective observational study and review of the literature. Scandinavian Journal of Gastroenterology. 53(4). 410–416. 17 indexed citations
6.
Nyhlin, Nils, Ashok Kumar Kumawat, Curt Tysk, et al.. (2013). IL-1/TLR signaling inhibitors in microscopic and ulcerative colitis : Immunopathogenic markers of active disease and remission. Immunology. 140. 167–167. 1 indexed citations
7.
Kumawat, Ashok Kumar, Hilja Strid, Curt Tysk, Johan Bohr, & Elisabeth Hultgren Hörnquist. (2013). Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Molecular Immunology. 55(3-4). 355–364. 58 indexed citations
8.
Münch, Andreas, Daniela E. Aust, Johan Bohr, et al.. (2012). Microscopic colitis: Current status, present and future challenges. Journal of Crohn s and Colitis. 6(9). 932–945. 152 indexed citations
9.
Münch, Andreas, et al.. (2011). Methotrexate is not effective in budesonide-refractory collagenous colitis. Gut. 60. 4 indexed citations
10.
Vigren, Lina, Klas Sjöberg, Cecilia Benoni, et al.. (2011). Is smoking a risk factor for collagenous colitis?. Scandinavian Journal of Gastroenterology. 46(11). 1334–1339. 73 indexed citations
11.
Hjortswang, Henrik, Curt Tysk, Johan Bohr, et al.. (2010). Health-related quality of life is impaired in active collagenous colitis. Digestive and Liver Disease. 43(2). 102–109. 60 indexed citations
12.
Hjortswang, Henrik, Curt Tysk, Johan Bohr, et al.. (2009). Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflammatory Bowel Diseases. 15(12). 1875–1881. 91 indexed citations
13.
Nyhlin, Nils, Johan Bohr, S. Eriksson, & Curt Tysk. (2006). Systematic review: microscopic colitis. Alimentary Pharmacology & Therapeutics. 23(11). 1525–1534. 78 indexed citations
14.
Wickbom, Anna, Magnus Lindqvist, Johan Bohr, et al.. (2006). Colonic mucosal tears in collagenous colitis. Scandinavian Journal of Gastroenterology. 41(6). 726–729. 50 indexed citations
15.
Bohr, Johan, Curt Tysk, Jon O. Lundberg, et al.. (2003). Luminal Nitric Oxide and Epithelial Expression of Inducible and Endothelial Nitric Oxide Synthase in Collagenous and Lymphocytic Colitis. Scandinavian Journal of Gastroenterology. 38(1). 66–72. 37 indexed citations
16.
Bohr, Johan, Roland Nordfelth, Gunnar Järnerot, & Curt Tysk. (2002). Yersinia Species in Collagenous Colitis: A Serologic Study. Scandinavian Journal of Gastroenterology. 37(6). 711–714. 56 indexed citations
17.
Bohr, Johan, Gunnar Järnerot, Curt Tysk, Ian Jones, & Sune Eriksson. (2002). Effect of Fasting on Diarrhoea in Collagenous Colitis. Digestion. 65(1). 30–34. 20 indexed citations
18.
Yang, Ping, Johan Bohr, Curt Tysk, Dan Danielsson, & Gunnar Järnerot. (1996). Antineutrophil cytoplasmic antibodies in inflammatory bowel disease and collagenous colitis: No association with lactoferrin, β-glucuronidase, myeloperoxidase, or proteinase 3. Inflammatory Bowel Diseases. 2(3). 173–177. 11 indexed citations
19.
Bohr, Johan, Ian L. Jones, Curt Tysk, & Gunnar Järnerot. (1995). Serum Procollagen III Propeptide Is Not of Diagnostic Predictive Value in Collagenous Colitis. Inflammatory Bowel Diseases. 1(4). 276–279. 3 indexed citations
20.
Bohr, Johan, Curt Tysk, Sven Eriksson, et al.. (1994). Plenary oral presentations. Gut. 35(4 Suppl). A2–A3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene F. Yen Breakdown of academic impact, for papers by Eric Vasiliauskas Breakdown of academic impact, for papers by Andrew Ippoliti Breakdown of academic impact, for papers by G d'Albasio Breakdown of academic impact, for papers by David F. Hutcheon Breakdown of academic impact, for papers by Valentina Discepolo Breakdown of academic impact, for papers by Edyta Zagórowicz Breakdown of academic impact, for papers by Nobuyuki Hida Breakdown of academic impact, for papers by Alicia Algaba Breakdown of academic impact, for papers by Benedetta Terziroli Beretta‐Piccoli
Rankless by CCL
2026